DOI QR코드

DOI QR Code

Hemostatic Dysfunction in a Dog with Mammary Gland Carcinoma

  • Rankyung, Jung (College of Veterinary Medicine, Gyeongsang National University) ;
  • Hyeona, Bae (College of Veterinary Medicine, Gyeongsang National University) ;
  • ARom, Cho (College of Veterinary Medicine, Gyeongsang National University) ;
  • Young Ju, Kim (College of Veterinary Medicine, Gyeongsang National University) ;
  • Yeseul, Jun (College of Veterinary Medicine, Gyeongsang National University) ;
  • Minji, Kim (College of Veterinary Medicine, Gyeongsang National University) ;
  • Sumin, Cha (College of Veterinary Medicine, Gyeongsang National University) ;
  • Min-Jeong, Kang (College of Veterinary Medicine, Gyeongsang National University) ;
  • Tae-Sung, Hwang (College of Veterinary Medicine, Gyeongsang National University) ;
  • Hee-Chun, Lee (College of Veterinary Medicine, Gyeongsang National University) ;
  • Kyu-Woan, Cho (College of Veterinary Medicine, Gyeongsang National University) ;
  • Dong-In, Jung (College of Veterinary Medicine, Gyeongsang National University) ;
  • Dae Young, Kim (College of Veterinary Medicine, University of Missouri) ;
  • DoHyeon, Yu (College of Veterinary Medicine, Gyeongsang National University)
  • Received : 2022.10.13
  • Accepted : 2022.11.23
  • Published : 2022.12.31

Abstract

Hypercoagulability is the most common coagulopathy seen in dogs with neoplasia, whereas a hypocoagulable state is relatively rare. A 16-year-old spayed female miniature Schnauzer presented with bilateral epistaxis, bilateral hindlimb swelling, and lameness. Previously, the dog was diagnosed with intermediate grade solid carcinoma after mastectomy, and then showed generalized ecchymoses on the abdomen and bilateral hindlimbs on presentation. Laboratory tests revealed a hypocoagulable state, including thrombocytopenia, hypofibrinogenemia, and delayed prothrombin and activated partial thromboplastin time. Thromboelastography demonstrated a prolonged K time with a decreased alpha angle and low maximal amplitude, reflecting a decrease in clot strength. The hypocoagulable state of disseminated intravascular coagulopathy was speculated based on the presence of an underlying tumor, clinical symptoms, and laboratory results of the hypocoagulable state. This case shows the incidence of hemostatic dysfunction as a paraneoplastic syndrome in a dog with mammary gland carcinoma.

Keywords

Acknowledgement

This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2017R1D1A1B03034904) (2020R1C1C1008675), and by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET) through Companion Animal Life Cycle Industry Technology Development Program, funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA) (322092-04-1-HD030).

References

  1. Bailey DB. Paraneoplastic syndromes. In: Vail DM, Thamm DH, Liptak J, editors. Withrow and MacEwen's small animal clinical oncology. 6th ed. Philadelphia: Elsevier Health Sciences. 2020: 98-112. 
  2. Boral BM, Williams DJ, Boral LI. Disseminated intravascular coagulation. Am J Clin Pathol 2016; 146: 670-680.  https://doi.org/10.1093/ajcp/aqw195
  3. de M Souza CH, Toledo-Piza E, Amorin R, Barboza A, Tobias KM. Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment. Can Vet J 2009; 50: 506-510. 
  4. Duda NCB, Valle SF, Matheus JP, Angeli NC, Vieira LC, Oliveira LO, et al. Paraneoplastic hematological, biochemical, and hemostatic abnormalities in female dogs with mammary neoplasms. Pesq Vet Bras 2017; 37: 479-484.  https://doi.org/10.1590/s0100-736x2017000500009
  5. Hunt BJ. Bleeding and coagulopathies in critical care. N Engl J Med 2014; 370: 847-859.  https://doi.org/10.1056/NEJMra1208626
  6. Kristensen AT, Wiinberg B, Jessen LR, Andreasen E, Jensen AL. Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia. J Vet Intern Med 2008; 22: 140-147.  https://doi.org/10.1111/j.1939-1676.2008.0030.x
  7. Lallo MA, Ferrarias TM, Stravino A, Rodriguez JFM, Zucare RLC. Hematologic abnormalities in dogs bearing mammary tumor. R Bras Ci Vet 2016; 23: 3-8.  https://doi.org/10.4322/rbcv.2016.020
  8. Marconato L, Romanelli G, Stefanello D, Giacoboni C, Bonfanti U, Bettini G, et al. Prognostic factors for dogs with mammary inflammatory carcinoma: 43 cases (2003-2008). J Am Vet Med Assoc 2009; 235: 967-972.  https://doi.org/10.2460/javma.235.8.967
  9. Maruyama H, Miura T, Sakai M, Koie H, Yamaya Y, Shibuya H, et al. The incidence of disseminated intravascular coagulation in dogs with malignant tumor. J Vet Med Sci 2004; 66: 573-575.  https://doi.org/10.1292/jvms.66.573
  10. Oliveira MR, Carneiro RA, Nunes FC, Teixeira SV, Vieira TC, Lavalle GE, et al. Hematological and biochemical alterations in female dogs with mammary cancer and inflammatory carcinoma. Arq Bras Med Vet Zootec 2022; 74: 428-436.  https://doi.org/10.1590/1678-4162-12471
  11. Papageorgiou C, Jourdi G, Adjambri E, Walborn A, Patel P, Fareed J, et al. Disseminated intravascular coagulation: an update on pathogenesis, diagnosis, and therapeutic strategies. Clin Appl Thromb Hemost 2018; 24(9_suppl): 8S-28S.  https://doi.org/10.1177/1076029618806424
  12. Singletary SE, Cristofanilli M. Defining the clinical diagnosis of inflammatory breast cancer. Semin Oncol 2008; 35: 7-10.  https://doi.org/10.1053/j.seminoncol.2007.11.010
  13. Stockhaus C, Kohn B, Rudolph R, Brunnberg L, Giger U. Correlation of haemostatic abnormalities with tumour stage and characteristics in dogs with mammary carcinoma. J Small Anim Pract 1999; 40: 326-331. https://doi.org/10.1111/j.1748-5827.1999.tb03090.x